950 related articles for article (PubMed ID: 11793371)
1. Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
Tallini G; Dorfman H; Brys P; Dal Cin P; De Wever I; Fletcher CD; Jonson K; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Samson I; Sciot R; Van den Berghe H; Vanni R; Willén H
J Pathol; 2002 Feb; 196(2):194-203. PubMed ID: 11793371
[TBL] [Abstract][Full Text] [Related]
2. Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors.
Sawyer JR; Swanson CM; Lukacs JL; Nicholas RW; North PE; Thomas JR
Cancer; 1998 Feb; 82(3):474-83. PubMed ID: 9452264
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic and spectral karyotype analyses of benign and malignant cartilage tumours.
Sjögren H; Orndal C; Tingby O; Meis-Kindblom JM; Kindblom LG; Stenman G
Int J Oncol; 2004 Jun; 24(6):1385-91. PubMed ID: 15138578
[TBL] [Abstract][Full Text] [Related]
4. IDH1 mutations are not found in cartilaginous tumours other than central and periosteal chondrosarcomas and enchondromas.
Damato S; Alorjani M; Bonar F; McCarthy SW; Cannon SR; O'Donnell P; Tirabosco R; Amary MF; Flanagan AM
Histopathology; 2012 Jan; 60(2):363-5. PubMed ID: 22074484
[No Abstract] [Full Text] [Related]
5. Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression.
van Beerendonk HM; Rozeman LB; Taminiau AH; Sciot R; Bovée JV; Cleton-Jansen AM; Hogendoorn PC
J Pathol; 2004 Mar; 202(3):359-66. PubMed ID: 14991902
[TBL] [Abstract][Full Text] [Related]
6. Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
Fletcher CD; Akerman M; Dal Cin P; de Wever I; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; van den Berghe H; van de Ven W; Vanni R; Willen H
Am J Pathol; 1996 Feb; 148(2):623-30. PubMed ID: 8579124
[TBL] [Abstract][Full Text] [Related]
7. Comparative genomic hybridization in cartilaginous tumors.
Ozaki T; Wai D; Schäfer KL; Lindner N; Böcker W; Winkelmann W; Dockhorn-Dworniczak B; Poremba C
Anticancer Res; 2004; 24(3a):1721-5. PubMed ID: 15274346
[TBL] [Abstract][Full Text] [Related]
8. Benign cartilaginous tumors of bone: from morphology to somatic and germ-line genetics.
Romeo S; Hogendoorn PC; Dei Tos AP
Adv Anat Pathol; 2009 Sep; 16(5):307-15. PubMed ID: 19700940
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
[TBL] [Abstract][Full Text] [Related]
10. The pericentromeric inversion, inv (6)(p25q13), is a novel diagnostic marker in chondromyxoid fibroma.
Granter SR; Renshaw AA; Kozakewich HP; Fletcher JA
Mod Pathol; 1998 Nov; 11(11):1071-4. PubMed ID: 9831204
[TBL] [Abstract][Full Text] [Related]
11. [Pathology of myxoid bone tumors of the skull base].
Gavril C; Bouvier C; Liprandi A; Dufour H; Peragut JC; Zanaret M; Figarella-Branger D
Ann Pathol; 2002 Sep; 22(4):259-66. PubMed ID: 12410148
[TBL] [Abstract][Full Text] [Related]
12. D2-40 functions as an effective chondroid marker distinguishing true chondroid tumors from chordoma.
Huse JT; Pasha TL; Zhang PJ
Acta Neuropathol; 2007 Jan; 113(1):87-94. PubMed ID: 17021752
[TBL] [Abstract][Full Text] [Related]
13. Primary bone tumors. MR morphologic appearance correlated with pathologic examinations.
Golfieri R; Baddeley H; Pringle JS; Leung AW; Greco A; Souhami R; Kemp H
Acta Radiol; 1991 Jul; 32(4):290-8. PubMed ID: 1650569
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic findings in clear cell chondrosarcoma.
Nishio J; Reith JD; Ogose A; Maale G; Neff JR; Bridge JA
Cancer Genet Cytogenet; 2005 Oct; 162(1):74-7. PubMed ID: 16157204
[TBL] [Abstract][Full Text] [Related]
15. ERG expression in chondrogenic bone and soft tissue tumours.
Shon W; Folpe AL; Fritchie KJ
J Clin Pathol; 2015 Feb; 68(2):125-9. PubMed ID: 25378537
[TBL] [Abstract][Full Text] [Related]
16. Cartilage-forming tumors.
Qasem SA; DeYoung BR
Semin Diagn Pathol; 2014 Jan; 31(1):10-20. PubMed ID: 24680178
[TBL] [Abstract][Full Text] [Related]
17. [Benign cartilaginous tumors].
Erlemann R
Radiologe; 2001 Jul; 41(7):548-59. PubMed ID: 11490775
[TBL] [Abstract][Full Text] [Related]
18. Soft Tissue Special Issue: Chondroid Neoplasms of the Skull.
Flaman AN; Wasserman JK; Gravel DH; Purgina BM
Head Neck Pathol; 2020 Mar; 14(1):83-96. PubMed ID: 31950468
[TBL] [Abstract][Full Text] [Related]
19. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
[TBL] [Abstract][Full Text] [Related]
20. Cytomorphologic features of chondroid neoplasms: a comparative study.
Chhabra S; Chopra R; Handa U; Punia RS; Mohan H
Acta Cytol; 2010; 54(6):1101-10. PubMed ID: 21428156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
